Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use
Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
More information
Scope and Contents
Contents
Natalizumab therapy for patients with multiple sclerosis (MS) has been associated with both improved clinical outcomes and an increased incidence of progressive multifocal leukoencephalopathy (PML). We provide details of the etiology and recent history of PML as associated with immunosuppressive disease states, including MS. Furthermore, it offers...
Alternative Titles
Full title
Clinical vigilance for progressive multifocal leukoencephalopathy in the context of natalizumab use
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_218849641
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_218849641
Other Identifiers
ISSN
1352-4585
E-ISSN
1477-0970
DOI
10.1177/1352458509347130
